Sonja I Berndt

Author PubWeight™ 278.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010 23.08
2 Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2008 22.35
3 Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010 20.01
4 Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008 17.65
5 Identification of ten loci associated with height highlights new biological pathways in human growth. Nat Genet 2008 16.25
6 Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008 15.94
7 Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 2010 7.94
8 Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 2013 5.58
9 Complications after prostate biopsy: data from SEER-Medicare. J Urol 2011 5.40
10 Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 2006 4.13
11 Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare. J Urol 2012 4.11
12 Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet 2012 3.69
13 Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet 2012 3.68
14 Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet 2011 3.07
15 The landscape of recombination in African Americans. Nature 2011 3.06
16 Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet 2013 2.83
17 FTO genotype is associated with phenotypic variability of body mass index. Nature 2012 2.77
18 Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet 2011 2.70
19 Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology 2012 2.57
20 Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet 2011 2.51
21 Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet 2008 2.45
22 Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet 2011 2.35
23 Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet 2012 2.26
24 Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet 2013 2.21
25 Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis 2009 2.17
26 Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 2006 2.06
27 Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer 2009 2.01
28 A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet 2013 1.82
29 Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet 2013 1.78
30 Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet 2011 1.77
31 Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour. J Med Genet 2011 1.73
32 Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev 2008 1.59
33 Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res 2012 1.58
34 Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study. Cancer Epidemiol Biomarkers Prev 2007 1.58
35 Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. PLoS Genet 2011 1.54
36 Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res 2006 1.52
37 Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry. PLoS Genet 2011 1.47
38 A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet 2012 1.47
39 Variation in lung cancer risk by smoky coal subtype in Xuanwei, China. Int J Cancer 2008 1.45
40 Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. PLoS One 2011 1.41
41 Improved imputation of common and uncommon SNPs with a new reference set. Nat Genet 2011 1.34
42 Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer 2005 1.32
43 Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis 2006 1.32
44 Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev 2012 1.29
45 Meta-analysis of gene-level associations for rare variants based on single-variant statistics. Am J Hum Genet 2013 1.24
46 Genome-wide analysis of BMI in adolescents and young adults reveals additional insight into the effects of genetic loci over the life course. Hum Mol Genet 2013 1.23
47 Selected genetic polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2005 1.19
48 Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk. Cancer Res 2009 1.18
49 Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. Hum Mol Genet 2011 1.17
50 Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer. Cancer Epidemiol Biomarkers Prev 2010 1.17
51 Genome-wide association study of relative telomere length. PLoS One 2011 1.16
52 PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). Carcinogenesis 2009 1.13
53 Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity. Carcinogenesis 2008 1.10
54 Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk. Cancer Epidemiol Biomarkers Prev 2006 1.07
55 Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. Cancer Res 2010 1.06
56 Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China. Lung Cancer 2005 1.05
57 Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol 2012 1.05
58 Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China. Anticancer Res 2005 1.04
59 A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. J Clin Endocrinol Metab 2010 1.04
60 Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. Carcinogenesis 2007 1.02
61 Telomere length and variation in telomere biology genes in individuals with osteosarcoma. Int J Mol Epidemiol Genet 2010 1.01
62 Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3). Hum Mol Genet 2009 1.01
63 A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33. Hum Genet 2009 1.01
64 Pesticide use modifies the association between genetic variants on chromosome 8q24 and prostate cancer. Cancer Res 2010 1.00
65 GST genotypes and lung cancer susceptibility in Asian populations with indoor air pollution exposures: a meta-analysis. Mutat Res 2007 1.00
66 A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma. BMC Cancer 2011 1.00
67 Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2. Cancer Epidemiol Biomarkers Prev 2010 0.99
68 Variants in blood pressure genes and the risk of renal cell carcinoma. Carcinogenesis 2010 0.99
69 HNF1B and JAZF1 genes, diabetes, and prostate cancer risk. Prostate 2010 0.98
70 Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. Cancer Res 2009 0.97
71 CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 2009 0.97
72 Polymorphisms in estrogen-metabolizing and estrogen receptor genes and the risk of developing breast cancer among a cohort of women with benign breast disease. BMC Cancer 2006 0.96
73 Generalizability of established prostate cancer risk variants in men of African ancestry. Int J Cancer 2014 0.96
74 Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Carcinogenesis 2013 0.96
75 Genotype frequency and F ST analysis of polymorphisms in immunoregulatory genes in Chinese and Caucasian populations. Immunogenetics 2007 0.96
76 Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. J Clin Oncol 2013 0.95
77 Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. Hum Genet 2015 0.95
78 Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and meta-analysis. Cancer Epidemiol Biomarkers Prev 2010 0.95
79 Replication of five prostate cancer loci identified in an Asian population--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev 2011 0.95
80 Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk. Leuk Res 2009 0.94
81 An analysis of growth, differentiation and apoptosis genes with risk of renal cancer. PLoS One 2009 0.93
82 Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women. Pharmacogenet Genomics 2006 0.93
83 Alcohol dehydrogenase genetic polymorphisms, low-to-moderate alcohol consumption, and risk of breast cancer. Alcohol Clin Exp Res 2007 0.93
84 Genetic variation at chromosome 8q24 in osteosarcoma cases and controls. Carcinogenesis 2010 0.92
85 Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia. Gut 2013 0.92
86 Fine-mapping of genome-wide association study-identified risk loci for colorectal cancer in African Americans. Hum Mol Genet 2013 0.92
87 Prospective study of genomic hypomethylation of leukocyte DNA and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2012 0.91
88 Nitric oxide synthase gene polymorphisms and prostate cancer risk. Carcinogenesis 2009 0.91
89 Common genetic variants and central adiposity among Asian-Indians. Obesity (Silver Spring) 2011 0.91
90 Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels. Hum Genet 2011 0.90
91 Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer. Pharmacogenet Genomics 2011 0.89
92 Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma. Environ Mol Mutagen 2012 0.89
93 Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2005 0.89
94 Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk. Cancer Res 2006 0.89
95 Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma. Int J Cancer 2011 0.88
96 Genetic variation in nucleotide excision repair pathway genes, pesticide exposure and prostate cancer risk. Carcinogenesis 2011 0.88
97 Meat-related mutagen exposure, xenobiotic metabolizing gene polymorphisms and the risk of advanced colorectal adenoma and cancer. Carcinogenesis 2012 0.88
98 Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer. Hum Genet 2009 0.88
99 Occupational sunlight exposure and risk of renal cell carcinoma. Cancer 2010 0.87
100 Smoky coal exposure, NBS1 polymorphisms, p53 protein accumulation, and lung cancer risk in Xuan Wei, China. Lung Cancer 2005 0.87
101 Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead. PLoS One 2011 0.87
102 DNA repair gene polymorphisms and tobacco smoking in the risk for colorectal adenomas. Carcinogenesis 2011 0.87
103 Genetic variation in base excision repair pathway genes, pesticide exposure, and prostate cancer risk. Environ Health Perspect 2011 0.86
104 A report of cytokine polymorphisms and COPD risk in Xuan Wei, China. Int J Hyg Environ Health 2007 0.86
105 Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer. Int J Cancer 2013 0.84
106 Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Int J Cancer 2013 0.84
107 Genetic contributions to the association between adult height and testicular germ cell tumors. Int J Epidemiol 2011 0.84
108 Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2013 0.84
109 Genetic variants of adiponectin and risk of colorectal cancer. Int J Cancer 2014 0.84
110 Associations between genes in the one-carbon metabolism pathway and advanced colorectal adenoma risk in individuals with low folate intake. Cancer Epidemiol Biomarkers Prev 2012 0.84
111 Genetic variants reflecting higher vitamin e status in men are associated with reduced risk of prostate cancer. J Nutr 2014 0.83
112 Lack of association of transforming growth factor-beta1 polymorphisms and haplotypes with prostate cancer risk in the prostate, lung, colorectal, and ovarian trial. Cancer Epidemiol Biomarkers Prev 2007 0.83
113 Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol 2012 0.82
114 Genetic susceptibility loci, pesticide exposure and prostate cancer risk. PLoS One 2013 0.82
115 Nonsteroidal anti-inflammatory drugs and other analgesic use and bladder cancer in northern New England. Int J Cancer 2012 0.80
116 Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma. Prostate 2010 0.80
117 Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry. Hum Genet 2012 0.79
118 Polymorphisms in complement system genes and risk of non-Hodgkin lymphoma. Environ Mol Mutagen 2011 0.79
119 Xenobiotic metabolizing genes, meat-related exposures, and risk of advanced colorectal adenoma. World Rev Nutr Diet 2010 0.78
120 The Interaction between Pesticide Use and Genetic Variants Involved in Lipid Metabolism on Prostate Cancer Risk. J Cancer Epidemiol 2012 0.78
121 Comprehensive resequence analysis of a 123-kb region of chromosome 11q13 associated with prostate cancer. Prostate 2012 0.77
122 Corrigendum: Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nat Commun 2015 0.76
123 Innate immunity gene polymorphisms and the risk of colorectal neoplasia. Carcinogenesis 2013 0.75
124 Xenobiotic metabolizing genes, meat-related exposures, and risk of advanced colorectal adenoma. J Nutrigenet Nutrigenomics 2011 0.75
125 Correction: The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study. PLoS Genet 2016 0.75
126 Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3. Am J Epidemiol 2017 0.75
127 Aspirin use and mortality in two contemporary U.S. cohorts. Epidemiology 2017 0.75
128 Interactions between household air pollution and GWAS-identified lung cancer susceptibility markers in the Female Lung Cancer Consortium in Asia (FLCCA). Hum Genet 2015 0.75